Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: CTMX stock price vs DT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DT's multiple
Needs DT P/S.
Implied fair value · at CTMX's multiple
Needs CTMX P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CTMX FY 2025 (ended Dec 31, 2025) · DT FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
CytomX Therapeutics, Inc. · implied price per share
Bear
$0.44
Base
$0.52
Bull
$0.60
Dynatrace, Inc. · implied price per share
Bear
$9.13
Base
$10.74
Bull
$12.35
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.03x
0.11x
Net debt / EBITDA
Leverage against operating earnings
20.51x
-2.78x
Cash and equivalents
Liquid reserves on the balance sheet
$292.06M
$1.19B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
IDEAYA Biosciences, Inc.
CTMX vs IDYA
EXELIXIS, INC.
CTMX vs EXEL
GILEAD SCIENCES, INC.
CTMX vs GILD
AMGEN INC
CTMX vs AMGN
AbbVie Inc.
CTMX vs ABBV
BRISTOL MYERS SQUIBB CO
CTMX vs BMY
Salesforce, Inc.
CTMX vs CRM
ADOBE INC.
CTMX vs ADBE
ORACLE CORP
CTMX vs ORCL
MICROSOFT CORP
CTMX vs MSFT
CISCO SYSTEMS, INC.
CTMX vs CSCO
INTERNATIONAL BUSINESS MACHINES CORP
CTMX vs IBM
$2.99M
$283.42M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
